290 related articles for article (PubMed ID: 36815693)
1. Molecular Recognition of GalNAc in Mucin-Type O-Glycosylation.
Sanz-Martinez I; Pereira S; Merino P; Corzana F; Hurtado-Guerrero R
Acc Chem Res; 2023 Mar; 56(5):548-560. PubMed ID: 36815693
[TBL] [Abstract][Full Text] [Related]
2. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
[TBL] [Abstract][Full Text] [Related]
3. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
4. Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.
Revoredo L; Wang S; Bennett EP; Clausen H; Moremen KW; Jarvis DL; Ten Hagen KG; Tabak LA; Gerken TA
Glycobiology; 2016 Apr; 26(4):360-76. PubMed ID: 26610890
[TBL] [Abstract][Full Text] [Related]
5. The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
Gerken TA; Revoredo L; Thome JJ; Tabak LA; Vester-Christensen MB; Clausen H; Gahlay GK; Jarvis DL; Johnson RW; Moniz HA; Moremen K
J Biol Chem; 2013 Jul; 288(27):19900-14. PubMed ID: 23689369
[TBL] [Abstract][Full Text] [Related]
6. Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.
Marcelo F; Garcia-Martin F; Matsushita T; Sardinha J; Coelho H; Oude-Vrielink A; Koller C; André S; Cabrita EJ; Gabius HJ; Nishimura S; Jiménez-Barbero J; Cañada FJ
Chemistry; 2014 Dec; 20(49):16147-55. PubMed ID: 25324212
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the synthesis of the core 1 structure by C1GalT1.
González-Ramírez AM; Grosso AS; Yang Z; Compañón I; Coelho H; Narimatsu Y; Clausen H; Marcelo F; Corzana F; Hurtado-Guerrero R
Nat Commun; 2022 May; 13(1):2398. PubMed ID: 35504880
[TBL] [Abstract][Full Text] [Related]
8. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
[TBL] [Abstract][Full Text] [Related]
9. Structural and mechanistic insights into the cleavage of clustered O-glycan patches-containing glycoproteins by mucinases of the human gut.
Taleb V; Liao Q; Narimatsu Y; García-García A; Compañón I; Borges RJ; González-Ramírez AM; Corzana F; Clausen H; Rovira C; Hurtado-Guerrero R
Nat Commun; 2022 Jul; 13(1):4324. PubMed ID: 35882872
[TBL] [Abstract][Full Text] [Related]
10. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
11. Serine versus threonine glycosylation with α-O-GalNAc: unexpected selectivity in their molecular recognition with lectins.
Madariaga D; Martínez-Sáez N; Somovilla VJ; García-García L; Berbis MÁ; Valero-Gónzalez J; Martín-Santamaría S; Hurtado-Guerrero R; Asensio JL; Jiménez-Barbero J; Avenoza A; Busto JH; Corzana F; Peregrina JM
Chemistry; 2014 Sep; 20(39):12616-27. PubMed ID: 25111627
[TBL] [Abstract][Full Text] [Related]
12. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
Brockhausen I; Dowler T; Paulsen H
Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
[TBL] [Abstract][Full Text] [Related]
13. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
Perrine CL; Ganguli A; Wu P; Bertozzi CR; Fritz TA; Raman J; Tabak LA; Gerken TA
J Biol Chem; 2009 Jul; 284(30):20387-97. PubMed ID: 19460755
[TBL] [Abstract][Full Text] [Related]
14. Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.
Pedersen JW; Bennett EP; Schjoldager KT; Meldal M; Holmér AP; Blixt O; Cló E; Levery SB; Clausen H; Wandall HH
J Biol Chem; 2011 Sep; 286(37):32684-96. PubMed ID: 21768105
[TBL] [Abstract][Full Text] [Related]
15. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
[TBL] [Abstract][Full Text] [Related]
16. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
[TBL] [Abstract][Full Text] [Related]
17. An unusual dual sugar-binding lectin domain controls the substrate specificity of a mucin-type O-glycosyltransferase.
Collette AM; Hassan SA; Schmidt SI; Lara AJ; Yang W; Samara NL
Sci Adv; 2024 Mar; 10(9):eadj8829. PubMed ID: 38416819
[TBL] [Abstract][Full Text] [Related]
18. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
19. In vitro synthesis of mucin-type O-glycans using saccharide primers comprising GalNAc-Ser and GalNAc-Thr residues.
Sakura R; Nagai K; Yagi Y; Takahashi Y; Ide Y; Yagi Y; Yamamoto D; Mizuno M; Sato T
Carbohydr Res; 2022 Jan; 511():108495. PubMed ID: 35026558
[TBL] [Abstract][Full Text] [Related]
20. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat. Further evidence for the modulation of O-glycans side chain structures by peptide sequence.
Gerken TA; Gilmore M; Zhang J
J Biol Chem; 2002 Mar; 277(10):7736-51. PubMed ID: 11777921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
